The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Heal
Requests for brand name over generic prescription drugs cost Medicare $1.7 billion in a single year
